Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

BACKGROUND: To get insight in the prevalence of high, or low/no serum infliximab trough levels in patients with low disease activity and if serum trough levels are stable and reliable longitudinally we conducted a prospective cohort study METHODS: In a longitudinal, observational cohort of RA patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van der Maas, Aatke, van den Bemt, Bart JF, Wolbink, Gertjan, van den Hoogen, Frank HJ, van Riel, Piet LCM, den Broeder, Alfons A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520787/
https://ncbi.nlm.nih.gov/pubmed/23006627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-13-184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados